Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Akoya Biosciences (AKYA)
NASDAQ:AKYA
Holding AKYA?
Track your performance easily
See the Price Targets and Ratings of:
AKYA Analyst Ratings
Moderate Buy
2 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AKYA Stock 12 Month Forecast
Average Price Target
$5.50
▲(73.50% Upside)
| Highest Price Target$7.00 | Average Price Target$5.50 | Lowest Price Target$4.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Craig-Hallum
Reiterated
09/16/24
Piper Sandler
Assigned
08/13/24
J.P. Morgan
―
Hold
―
Downgraded
08/06/24
Akoya Biosciences downgraded to Neutral from Overweight at JPMorganAkoya Biosciences downgraded to Neutral from Overweight at JPMorgan
Morgan Stanley
$4→$3
Hold
-5.36%
Downside
Downgraded
08/06/24
Hold Rating on Akoya Biosciences Amidst Solid Operations and Market Headwinds
BTIG
―
Hold
―
Downgraded
08/06/24
Akoya Biosciences (AKYA) was downgraded to a Hold Rating at BTIG
Canaccord Genuity
$6
Buy
89.27%
Upside
Reiterated
06/24/24
Akoya Biosciences: Poised for Growth in Spatial Biology and Precision Medicine
UBS
$7→$7.5
Buy
136.59%
Upside
Reiterated
03/05/24
Akoya Biosciences Inc (AKYA) PT Raised to $7.50 at UBSUBS analyst John Sourbeer raised the price target on Akoya Biosciences Inc (NASDAQ: AKYA) to $7.50 (from $7.00) while maintaining a Buy rating.
Stephens
$14→$9
Buy
183.91%
Upside
Reiterated
11/13/23
Akoya Biosciences price target lowered to $9 from $14 at StephensAkoya Biosciences price target lowered to $9 from $14 at Stephens
Unknown Analyst
Not Ranked
Guggenheim
―
Hold
―
Initiated
12/14/23
Akoya Biosciences initiated with neutral view at Guggenheim, here's whyAkoya Biosciences initiated with neutral view at Guggenheim, here's why
Best Analysts Covering Akoya Biosciences
Which Analyst Should I Follow If I Want to Buy AKYA and Sell After:
1 Month
xxx
Success Rate
7/15 ratings generated profit
Average Return
-4.63%
assigned a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 46.67% of your transactions generating a profit, with an average return of -4.63% per trade.
3 Months
xxx
Success Rate
3/7 ratings generated profit
Average Return
-9.14%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of -9.14% per trade.
1 Year
Success Rate
1/7 ratings generated profit
Average Return
-23.43%
reiterated a buy rating 5 months ago
Copying Kyle Mikson CFA's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -23.43% per trade.
2 Years
xxx
Success Rate
1/7 ratings generated profit
Average Return
-29.76%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 14.29% of your transactions generating a profit, with an average return of -29.76% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AKYA Analyst Recommendation Trends
Rating
May 24
Jun 24
Jul 24
Aug 24
Sep 24
Strong Buy
9
7
7
6
5
Buy
2
1
1
0
0
Hold
0
0
0
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
8
8
9
8
Each month's total comprises the sum of three months' worth of ratings.
AKYA Financial Forecast
AKYA Stock Forecast FAQ
What is AKYA’s average 12-month price target, according to analysts?
Based on analyst ratings, Akoya Biosciences’s 12-month average price target is $5.50.
What is AKYA’s upside potential, based on the analysts’ average price target?
Akoya Biosciences has 73.50% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AKYA a Buy, Sell or Hold?
Akoya Biosciences has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Akoya Biosciences’s price target?
The average price target for Akoya Biosciences is $5.50. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $7.00 ,the lowest forecast is $4.00. The average price target represents 73.50% Increase from the current price of $3.17.
The highest analyst price target is $7.00 ,the lowest forecast is $4.00. The average price target represents 73.50% Increase from the current price of $3.17.
What do analysts say about Akoya Biosciences?
Akoya Biosciences’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Streets Analysts.
How can I buy shares of AKYA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.